- Home
- HTH vs SLNO Comparison
HTH vs SLNO Comparison
Compare HTH & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTH
- SLNO
- Stock Information
- Founded
- HTH 1998
- SLNO 1999
- Country
- HTH United States
- SLNO United States
- Employees
- HTH N/A
- SLNO N/A
- Industry
- HTH Major Banks
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- HTH Finance
- SLNO Health Care
- Exchange
- HTH Nasdaq
- SLNO Nasdaq
- Market Cap
- HTH 1.9B
- SLNO 3.8B
- IPO Year
- HTH 2004
- SLNO 2014
- Fundamental
- Price
- HTH $31.91
- SLNO $86.65
- Analyst Decision
- HTH Hold
- SLNO Strong Buy
- Analyst Count
- HTH 2
- SLNO 9
- Target Price
- HTH $33.00
- SLNO $103.33
- AVG Volume (30 Days)
- HTH 419.0K
- SLNO 1.1M
- Earning Date
- HTH 07-24-2025
- SLNO 08-06-2025
- Dividend Yield
- HTH 2.26%
- SLNO N/A
- EPS Growth
- HTH 15.07
- SLNO N/A
- EPS
- HTH 1.97
- SLNO N/A
- Revenue
- HTH $1,208,822,000.00
- SLNO N/A
- Revenue This Year
- HTH N/A
- SLNO N/A
- Revenue Next Year
- HTH $1.36
- SLNO N/A
- P/E Ratio
- HTH $16.22
- SLNO N/A
- Revenue Growth
- HTH 2.13
- SLNO N/A
- 52 Week Low
- HTH $26.67
- SLNO $39.73
- 52 Week High
- HTH $35.32
- SLNO $87.16
- Technical
- Relative Strength Index (RSI)
- HTH 69.23
- SLNO 67.62
- Support Level
- HTH $30.20
- SLNO $81.61
- Resistance Level
- HTH $30.54
- SLNO $86.79
- Average True Range (ATR)
- HTH 0.56
- SLNO 3.10
- MACD
- HTH 0.23
- SLNO 0.33
- Stochastic Oscillator
- HTH 92.28
- SLNO 95.37
About HTH Hilltop Holdings Inc.
Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.